RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Scopolamine

prevention of nausea and vomiting associated with motion sickness, prevention of post-operative nausea and vomiting (PONV)

Indications

  • prevention of nausea and vomiting associated with motion sickness
  • prevention of post-operative nausea and vomiting (PONV)

Adult dosing

  • motion sickness: dose: 1; unit: patch; route: transdermal - transdermal system delivering 1 mg over 3 days; interval: behind one ear at least 4 h before needed; delivers 1 mg over 3 days; fixed: true; labelExcerpt: Apply one transdermal system to the hairless area behind one ear at least 4 hours before antiemetic effect is required

Pediatric dosing

  • Consult pharmacy/current label

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • Consider more frequent monitoring during treatment in patients with hepatic impairment due to increased risk of CNS adverse reactions.

Contraindications

  • angle closure glaucoma
  • hypersensitivity to scopolamine or other belladonna alkaloids

Clinical pearls

  • Apply at least 4 hours before antiemetic effect is needed.
  • Do not cut the patch; wash hands thoroughly after application and removal.
  • Remove patch and contact provider if hyperthermia or symptoms of acute angle closure glaucoma occur.
  • Monitor for CNS effects like hallucinations, confusion, and dizziness, especially in the elderly.

Source and review

  • DailyMed label (scopolamine), Set ID 804f580a-a6b9-4dca-b480-be3576682aa9, effective 2026-10-14. Last reviewed: 2026-11-11